Disclosures for "Idiopathic Hypertrophic Pachymeningitis: Diagnosis of Exclusion"
-
Dr. McGill has nothing to disclose.
-
Dr. Summay has nothing to disclose.
-
Mrs. Manikowski has nothing to disclose.
-
Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.